Annual SGA
$74.95 M
+$8.97 M+13.60%
December 31, 2023
Summary
- As of February 7, 2025, RLAY annual SGA is $74.95 million, with the most recent change of +$8.97 million (+13.60%) on December 31, 2023.
- During the last 3 years, RLAY annual SGA has risen by +$36.36 million (+94.23%).
- RLAY annual SGA is now at all-time high.
Performance
RLAY SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$19.75 M
-$389.00 K-1.93%
September 1, 2024
Summary
- As of February 7, 2025, RLAY quarterly SGA is $19.75 million, with the most recent change of -$389.00 thousand (-1.93%) on September 1, 2024.
- Over the past year, RLAY quarterly SGA has increased by +$1.26 million (+6.84%).
- RLAY quarterly SGA is now -1.93% below its all-time high of $20.14 million, reached on June 30, 2024.
Performance
RLAY Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$6.12 B
-$345.20 M-5.98%
September 1, 2024
Summary
- As of February 7, 2025, RLAY TTM SGA is -$6.12 billion, with the most recent change of -$345.20 million (-5.98%) on September 1, 2024.
- Over the past year, RLAY TTM SGA has dropped by -$6.19 billion (-8307.39%).
- RLAY TTM SGA is now -3129.34% below its all-time high of -$189.48 million.
Performance
RLAY TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RLAY Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.6% | +6.8% | -8307.4% |
| 3 y3 years | +94.2% | +34.5% | -10000.0% |
| 5 y5 years | +746.4% | +440.8% | -10000.0% |
RLAY Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.6% | -1.9% | +27.0% | -139.5% | at low |
| 5 y | 5-year | at high | +445.4% | -1.9% | +476.5% | -3129.3% | at low |
| alltime | all time | at high | +746.4% | -1.9% | +544.0% | -3129.3% | at low |
Relay Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $19.75 M(-1.9%) | $76.45 M(+1.7%) |
| Jun 2024 | - | $20.14 M(+1.7%) | $75.19 M(+0.0%) |
| Mar 2024 | - | $19.80 M(+18.1%) | $75.17 M(+0.3%) |
| Dec 2023 | $74.95 M(+13.6%) | $16.77 M(-9.3%) | $74.95 M(+0.5%) |
| Sep 2023 | - | $18.48 M(-8.1%) | $74.56 M(+3.3%) |
| Jun 2023 | - | $20.12 M(+2.8%) | $72.14 M(+3.8%) |
| Mar 2023 | - | $19.58 M(+19.6%) | $69.49 M(+5.3%) |
| Dec 2022 | $65.98 M(+15.0%) | $16.37 M(+1.8%) | $65.98 M(+1.3%) |
| Sep 2022 | - | $16.07 M(-8.0%) | $65.15 M(+2.2%) |
| Jun 2022 | - | $17.46 M(+8.7%) | $63.76 M(+5.0%) |
| Mar 2022 | - | $16.07 M(+3.4%) | $60.72 M(+5.8%) |
| Dec 2021 | $57.39 M | $15.55 M(+5.9%) | $57.39 M(+0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $14.68 M(+1.8%) | $57.38 M(+4.5%) |
| Jun 2021 | - | $14.42 M(+13.2%) | $54.93 M(+18.0%) |
| Mar 2021 | - | $12.73 M(-18.1%) | $46.56 M(+20.7%) |
| Dec 2020 | $38.59 M(+180.8%) | $15.54 M(+27.1%) | $38.59 M(+45.8%) |
| Sep 2020 | - | $12.23 M(+102.1%) | $26.47 M(+48.0%) |
| Jun 2020 | - | $6.05 M(+27.2%) | $17.89 M(+16.6%) |
| Mar 2020 | - | $4.76 M(+38.9%) | $15.34 M(+12.4%) |
| Dec 2019 | $13.74 M(+55.2%) | $3.43 M(-6.2%) | $13.65 M(+33.5%) |
| Sep 2019 | - | $3.65 M(+4.1%) | $10.23 M(+55.5%) |
| Jun 2019 | - | $3.51 M(+14.4%) | $6.58 M(+114.4%) |
| Mar 2019 | - | $3.07 M | $3.07 M |
| Dec 2018 | $8.86 M | - | - |
FAQ
- What is Relay Therapeutics annual SGA?
- What is the all time high annual SGA for Relay Therapeutics?
- What is Relay Therapeutics annual SGA year-on-year change?
- What is Relay Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Relay Therapeutics?
- What is Relay Therapeutics quarterly SGA year-on-year change?
- What is Relay Therapeutics TTM SGA?
- What is the all time high TTM SGA for Relay Therapeutics?
- What is Relay Therapeutics TTM SGA year-on-year change?
What is Relay Therapeutics annual SGA?
The current annual SGA of RLAY is $74.95 M
What is the all time high annual SGA for Relay Therapeutics?
Relay Therapeutics all-time high annual SGA is $74.95 M
What is Relay Therapeutics annual SGA year-on-year change?
Over the past year, RLAY annual SGA has changed by +$8.97 M (+13.60%)
What is Relay Therapeutics quarterly SGA?
The current quarterly SGA of RLAY is $19.75 M
What is the all time high quarterly SGA for Relay Therapeutics?
Relay Therapeutics all-time high quarterly SGA is $20.14 M
What is Relay Therapeutics quarterly SGA year-on-year change?
Over the past year, RLAY quarterly SGA has changed by +$1.26 M (+6.84%)
What is Relay Therapeutics TTM SGA?
The current TTM SGA of RLAY is -$6.12 B
What is the all time high TTM SGA for Relay Therapeutics?
Relay Therapeutics all-time high TTM SGA is -$189.48 M
What is Relay Therapeutics TTM SGA year-on-year change?
Over the past year, RLAY TTM SGA has changed by -$6.19 B (-8307.39%)